Leukocytosis Overview
Learn About Leukocytosis
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Advocate Good Samaritan Cancer Center
Katy Goldsborough is a Hematologist and an Oncologist in Downers Grove, Illinois. Dr. Goldsborough is rated as a Distinguished provider by MediFind in the treatment of Leukocytosis. Her top areas of expertise are Breast Cancer, Leukocytosis, Paget Disease of the Breast, and Pleuropulmonary Blastoma.
Mayo Clinic
Ayalew Tefferi is a Hematologist and an Oncologist in Rochester, Minnesota. Dr. Tefferi is rated as an Elite provider by MediFind in the treatment of Leukocytosis. His top areas of expertise are Essential Thrombocythemia, Myelofibrosis, Myeloproliferative Neoplasms (MPN), Splenectomy, and Bone Marrow Transplant. Dr. Tefferi is currently accepting new patients.
Mayo Clinic
Naseema Gangat is a Hematologist and an Oncologist in Rochester, Minnesota. Dr. Gangat is rated as an Elite provider by MediFind in the treatment of Leukocytosis. Her top areas of expertise are Myelofibrosis, Leukocytosis, Essential Thrombocythemia, Bone Marrow Aspiration, and Splenectomy. Dr. Gangat is currently accepting new patients.
Summary: The LALGFA2019 Recommendations redefine the standard risk criteria and propose to introduce anthracycline induction in so-called high-risk forms (LAL line T and LAL line B with leukocytosis greater than or equal to 50 G/L or in children less than 1 year of age or more than 10 years of age) as well as Endoxan and Methotrexate in high dose consolidation.
Summary: In Slovenia, tick-borne encephalitis and Lyme borreliosis are both endemic diseases with high incidence rates and they are both transmitted by a bite of infected Ixodes ricinus tick. In clinical practice, tick-borne encephalitis is confirmed by demonstration of tick-borne encephalitis antibodies in serum of a patient with compatible clinical presentation and cerebrospinal pleocytosis. Patients wit...
